BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10724022)

  • 1. Comparison of pivmecillinam and cephalexin in acute uncomplicated urinary tract infection.
    Menday AP
    Int J Antimicrob Agents; 2000 Jan; 13(3):183-7. PubMed ID: 10724022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pivmecillinam in the treatment of urinary tract infections.
    Nicolle LE
    J Antimicrob Chemother; 2000 Sep; 46 Suppl 1():35-9; discussion 63-5. PubMed ID: 11051622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pivmecillinam versus sulfamethizole for short-term treatment of uncomplicated acute cystitis in general practice: a randomized controlled trial.
    Bjerrum L; Gahrn-Hansen B; Grinsted P
    Scand J Prim Health Care; 2009; 27(1):6-11. PubMed ID: 18991182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An open, multi-centre evaluation of a 5-day course of pivmecillinam in urinary tract infections in general practice.
    Place C
    Pharmatherapeutica; 1981; 3(1):55-60. PubMed ID: 6275417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and bacteriological efficacy of pivmecillinam treatment for uncomplicated urinary tract infections caused by ESBL-producing Escherichia coli: a prospective, multicentre, observational cohort study.
    Bollestad M; Grude N; Solhaug S; Raffelsberger N; Handal N; Nilsen HS; Romstad MR; Emmert A; Tveten Y; Søraas A; Jenum PA; Jenum S; Møller-Stray J; Weme ET; Lindbaek M; Simonsen GS;
    J Antimicrob Chemother; 2018 Sep; 73(9):2503-2509. PubMed ID: 29982514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A general practice evaluation of pivmecillinam given twice daily as a treatment for acute urinary tract infection.
    Skinner JL; Venables TL; Sheldon MG
    Pharmatherapeutica; 1984; 4(1):25-31. PubMed ID: 6504945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative efficacy of 3-day and 7-day chemotherapy with twice-daily pivmecillinam in urinary tract infections seen in general practice.
    Richards HH
    Curr Med Res Opin; 1984; 9(3):197-203. PubMed ID: 6499513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and bacteriological effects of pivmecillinam for ESBL-producing Escherichia coli or Klebsiella pneumoniae in urinary tract infections.
    Jansåker F; Frimodt-Møller N; Sjögren I; Dahl Knudsen J
    J Antimicrob Chemother; 2014 Mar; 69(3):769-72. PubMed ID: 24107388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A fixed combination of pivmecillinam and pivampicillin in complicated urinary tract infections. Double-blind comparison with pivmecillinam alone in hospitalized patients.
    Scand J Infect Dis; 1983; 15(2):195-9. PubMed ID: 6308755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pivmecillinam plus pivampicillin in complicated urinary tract infection. Double-blind comparison of the combination pivmecillinam/pivampicillin and pivmecillinam alone in patients with urinary tract infection.
    Frimodt-Møller C; Vejlsgaard R
    J Int Med Res; 1981; 9(4):283-7. PubMed ID: 6266897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pivmecillinam--therapy of choice for lower urinary tract infection.
    Graninger W
    Int J Antimicrob Agents; 2003 Oct; 22 Suppl 2():73-8. PubMed ID: 14527775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and bacteriological outcome of different doses and duration of pivmecillinam compared with placebo therapy of uncomplicated lower urinary tract infection in women: the LUTIW project.
    Ferry SA; Holm SE; Stenlund H; Lundholm R; Monsen TJ
    Scand J Prim Health Care; 2007 Mar; 25(1):49-57. PubMed ID: 17354160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pivmecillinam treatment of chronic urinary tract infection.
    Kalager T; Bøe E; Digranes A; Høisaether P; Solberg CO
    Infection; 1978; 6(1):21-2. PubMed ID: 204581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three days of pivmecillinam or norfloxacin for treatment of acute uncomplicated urinary infection in women.
    Nicolle LE; Madsen KS; Debeeck GO; Blochlinger E; Borrild N; Bru JP; Mckinnon C; O'Doherty B; Spiegel W; Van Balen FA; Menday P
    Scand J Infect Dis; 2002; 34(7):487-92. PubMed ID: 12195873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pivmecillinam treatment in acute cystitis. Three versus seven days study.
    Pitkäjärvi T; Pyykönen ML; Kannisto K; Piippo T; Viita P
    Arzneimittelforschung; 1990 Oct; 40(10):1156-8. PubMed ID: 2291755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An open evaluation of a 3-day course of pivmecillinam (ten 200 mg tablets) in women with acute uncomplicated cystitis.
    Donald JF; Rimmer DM
    J Int Med Res; 1980; 8(2):112-7. PubMed ID: 6245977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative efficacy of 3-day and 7-day chemotherapy with pivmecillinam in urinary tract infections in general practice.
    Marsh BT; Menday AP
    J Int Med Res; 1980; 8(2):105-11. PubMed ID: 6245976
    [No Abstract]   [Full Text] [Related]  

  • 18. Pivmecillinam in uncomplicated urinary tract infections in general practice.
    Peddie BA; Little PJ
    N Z Med J; 1981 Feb; 93(678):109-11. PubMed ID: 6267530
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term treatment with pivmecillinam in patients with recurrent bacteriuria.
    Bresky B; Lincoln K
    J Int Med Res; 1982; 10(3):179-82. PubMed ID: 6284565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment duration of pivmecillinam in men, non-pregnant and pregnant women for community-acquired urinary tract infections caused by Escherichia coli: a retrospective Danish cohort study.
    Boel JB; Jansåker F; Hertz FB; Hansen KH; Thønnings S; Frimodt-Møller N; Knudsen JD
    J Antimicrob Chemother; 2019 Sep; 74(9):2767-2773. PubMed ID: 31098630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.